A clinical trial to evaluate the effect of levocetirizine on pruritic skin diseases.

A clinical trial to evaluate the effect of levocetirizine on pruritic skin diseases. - A clinical trial to evaluate the effect of levocetirizine on pruritic skin diseases.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008463

Enrollment

100

Registered

2012-07-20

Start date

2012-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritic skin diseases

Interventions

Six weeks-treatment with levocetirizine(5mg once daily) After 2 weeks-treatment with levocetirizine(5mg once daily), 4 weeks-treatment with levocetirizine(10mg once daily) After 2 weeks-treatment with

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients aged 16 years or older at the time of registration. 2)Patients who received an explanation of the study detail and signed a written consent form.

Exclusion criteria

Exclusion criteria: 1)Patients with an acute infection. 2)Patients treated with ultraviolet therapy or subcutaneous allergen-specific immunotherapy. 3)Patients treated with corticosteroid orally or injections. 4)Patients who drive a car or engaging in hazardous occupations. 5)Patients who are pregnant or possibly pregnant women, or breastfeeding women. 6)Patients who has sever complicating diseases like hepatic disease, kidney disease, hart disease. 7)Patients who are judged inappropriate to participate in the study by the investigator.

Design outcomes

Primary

Measure	Time frame
Itch: Visual analog scale	—

Secondary

Measure	Time frame
Itch: Scratch score Severity: Objective SCORAD QOL: DLQI, Skindex16 Daytime drowsiness: ESS Nocturnal sleep: Pittsburgh Sleep Quality Index (PSQI)	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026